Research & Development
Two-Year Novo Nordisk Foundation-funded Postdoc Position in Metabolic Signalling and Adipose Tissue Proteostasis
Summary
The postdoctoral fellow will investigate sheddokines and their protease regulators in adipose tissue, combining discovery proteomics with functional validation in cell and mouse models to explore potential therapeutic strategies for cardiometabolic disorders.
The fields are read by AI from the ad. If the employer filled in a field themselves, we use theirs.
Opportunity summary
Employment type: Full time. Requisition: 4477.
Are you a creative and motivated postdoc ready to uncover novel, therapeutically exploitable mechanisms in cardiometabolic disease?
Then join our dynamic research team to lead a groundbreaking project at the intersection of adipose tissue biology, cell signalling, in vivo physiology and obesity therapeutics!
We are seeking a talented postdoctoral fellow to join us at the Department of Biochemistry and Molecular Biology, University of Southern Denmark, in Odense.
This two-year position is funded by the Novo Nordisk Foundation, with a flexible start from 1.2.2027 and the possibility of extension in case of incurring follow-up funding.
The PRO-METeus project
Our lab is exploring a new frontier in endocrinology:
Sheddokines.
These are fragments of cell-surface proteins that are proteolytically cleaved and released to function as atypical hormones, orchestrating communication between adipose tissue and metabolic organs.
We have compelling evidence that this regulatory network is altered in obese rodents and patients, and the PRO-METeus project aims to identify novel sheddokines and their protease regulators to understand their role in health and disease. Your project will be to help decipher this complex signalling language, paving the way for new sheddokine-targeted therapies for cardiometabolic disorders.
As our next postdoctoral fellow, you will
- Identify protein fragments released from human and mouse adipocytes.
- Validate these candidates in vivo by manipulating their secretion in mouse models of cardiometabolic disease using adipocyte-specific AAVs.
- Decipher the molecular mechanisms that regulate shadowiness and their impact on inter-organ communication.
Collectively, PRO-METeus offers a unique opportunity to blend discovery proteomics with functional validation, directly translating your findings into potential therapeutic strategies.
This is an extract. Read the whole advert at Employer's career site